Research Article

Comparison between the HLA-B58 : 01 Allele and Single-Nucleotide Polymorphisms in Chromosome 6 for Prediction of Allopurinol-Induced Severe Cutaneous Adverse Reactions

Table 1

Demographic and clinical characteristics of allopurinol-induced SCARs and tolerant control patients.

Characteristic dataDRESS ()SJS/TEN ()SCARs ()Control ()

Age (year)Mean (SD)65 (14)65 (12)65 (12)64 (12)
Median (range)68 (28–82)68 (38–84)68 (28–84)66 (29–91)
GenderFemale; n (%)10 (43.48)40 (54.79)50 (52.08)49 (25.39)
Onset of SCARs (day)Mean (SD)29 (13)19 (11)21 (13)
Median (range)30 (10–60)18 (2–60)20 (2–60)
Allopurinol dose (mg)Mean (SD)171 (78)182 (106)179 (99)194 (90)
Median (range)200 (100–300)100 (50–600)100 (50–600)200 (100–600)
Indication of allopurinolHyperuricemia; n (%)11 (47.83)13 (17.81)24 (25.00)3 (1.55)
Gouty arthritis; n (%)12 (52.17)60 (82.19)72 (75.00)190 (98.45)
Baseline kidney function
Blood urine nitrogen (mg/dL)n142640129
Mean (SD)29.79 (21.14)24.85 (20.09)26.58 (20.33)18.63 (10.40)
Median (range)21.35 (11.00–80.00)18.50 (10.00–105.00)21.00 (10.00–105.00)16.20 (3.00–70.00)
Serum creatinine (mg/dL)n196584174
Mean (SD)2.20 (2.20)1.54 (1.05)1.69 (1.40)1.47 (1.46)
Median (range)1.40 (0.90–9.60)1.30 (0.50–8.82)1.30 (0.50–9.60)1.20 (0.70–14.80)
Estimated glomerular filtration rate (eGFR) (mL/min/1.73 m2)an196584174
Mean (SD)44.05 (21.99)48.61 (21.95)47.58 (21.91)58.01 (20.41)
Median (range)46.00 (6.54–88.61)45.27 (4.62–127.17)45.65 (4.62–127.17)57.45 (3.12–112.49)
eGFR < 30.00; n (%)4 (17.39)14 (19.18)18 (21.43)13 (7.47)
30.00 ≤ eGFR < 60.00; n (%)11 (47.83)37 (50.68)48 (57.14)78 (44.83)
eGFR ≥ 60.00; n (%)4 (17.39)14 (19.18)18 (21.43)83 (47.70)

aeGFR: estimated glomerular filtration rate (expressed as mL/min/1.73 m2) calculated by Modification of Diet in Renal the Disease (MDRD) study equation [39]. Indicated significant difference between case and tolerant control. value < 0.05, value < 0.01, value < 0.001, value < 0.0001, and value < 0.00001.